EUVIMEDEUVIMED entdecken
Crossref

Visually evaluating drug efficacy in living cells using COF-based fluorescent nanoprobe via CHA amplified detection of miRNA and simultaneous apoptosis imaging

Chuandong Ge, Zhe Chen, Heming Sun, Ping Sun, Jiayin Zhao, Yanjuan Wu, Jing Xu, Mingyang Zhou, Mingming Luan

Analytica Chimica Acta · 2024-05 · 1302 · 342502

DOI: 10.1016/j.aca.2024.342502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024-05. Verfasst von Chuandong Ge und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Functional Biomolecules, School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Ji…. Hauptthemen laut MEDLINE: MicroRNAs, Biosensing Techniques. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Shandong Academy of Sciences, Qilu University of Technology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUNDS: Cancer is a highly fatal disease which is close relative of miRNA aberrant expression and apoptosis disorders. Elucidation of the therapeutic efficacy through investigating the changes in miRNA and apoptosis holds immense importance in advancing the development of miRNA-based precision therapy. However, it remains a challenge as how to visually evaluate the efficacy during protocol optimization of miRNA-based anticancer drugs at the cellular level. Therefore, exploring effective and noninvasive methods for real-time monitoring of therapeutic efficacy in living cells is of great significance. RESULTS: Herein, we reported a novel fluorescent nanoprobe COF-H1/H2-Peptide for visually evaluating drug efficacy in living cells through amplified imaging of low-abundant miRNA-221 with catalytic hairpin assembly (CHA) circle amplification, as well as simultaneous caspase-3 imaging. With strong stability and good biocompatibility, this newly fabricated amplified nanoprobe showed high sensitivity and specificity for the detection of miRNA-221 and caspase-3, and the limit of detection (LOD) of miRNA-221 was as low as 2.79 pM. The fluorescent imaging results showed that this amplified nanoprobe could not only detect caspase-3 in living cells, but also effectively detect low levels of miRNA-221 with increasing anticancer drug concentration and treatment time. The smart nanoprobe had effective performance for optimizing miRNA-based drug treatment schedules by dual-color fluorescence imaging. SIGNIFICANCE: This nanoprobe combined CHA amplified detection of intracellular miRNA-221 and synchronous apoptosis imaging, with excellent sensitivity for the detection of cellular low-level miRNA, enabling the realization of real-time assessment of the efficacy of miRNA-based therapy in living cells. This work presents a promising approach for revealing the regulatory mechanisms between miRNAs and apoptosis in cancer occurrence, development, and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBiosensing TechniquesHumansCaspase 3ApoptosisHeLa CellsFluorescent Dyes

Stichwörter der Autor:innen

Amplified miRNA detectionApoptosis imagingFluorescent nanoprobeVisual efficacy evaluation

Substanzen

MicroRNAsCaspase 3Fluorescent DyesMIR221, human

Autor:innen und Institutionen

  • Institute for Functional Biomolecules, School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250353, PR China.
  • Textile Industrial Products Testing Center of Nanjing Customs District, Wuxi, 214101, PR China.
  • Institute for Functional Biomolecules, School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250353, PR China. Electronic address: myzhou@qlu.edu.cn.
  • Institute for Functional Biomolecules, School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250353, PR China. Electronic address: luanmm@qlu.edu.cn.

Förderung

  • Shandong Academy of Sciences
  • Qilu University of Technology
  • National Natural Science Foundation of China

Zitieren

APA

Ge, C., Chen, Z., Sun, H., Sun, P., Zhao, J., Wu, Y., Xu, J., Zhou, M., & Luan, M. (2024). Visually evaluating drug efficacy in living cells using COF-based fluorescent nanoprobe via CHA amplified detection of miRNA and simultaneous apoptosis imaging. Analytica Chimica Acta, 1302, 342502. https://doi.org/10.1016/j.aca.2024.342502

Vancouver

Ge C, Chen Z, Sun H, Sun P, Zhao J, Wu Y, et al. Visually evaluating drug efficacy in living cells using COF-based fluorescent nanoprobe via CHA amplified detection of miRNA and simultaneous apoptosis imaging. Analytica Chimica Acta. 2024;1302:342502. doi:10.1016/j.aca.2024.342502

BibTeX
@article{Ge2024,
  author = {Ge, Chuandong and Chen, Zhe and Sun, Heming and Sun, Ping and Zhao, Jiayin and Wu, Yanjuan and Xu, Jing and Zhou, Mingyang and Luan, Mingming},
  title = {Visually evaluating drug efficacy in living cells using COF-based fluorescent nanoprobe via CHA amplified detection of miRNA and simultaneous apoptosis imaging},
  journal = {Analytica Chimica Acta},
  year = {2024},
  volume = {1302},
  pages = {342502},
  doi = {10.1016/j.aca.2024.342502}
}
Kostenlos starten →